CIK 0001787400
- Non-accelerated filer
- Smaller reporting company
Nkarta, Inc.
Sign in to watch- Ticker
- NKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474515206
- Phone
- +1 925-407-1049
- Business address
- 1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale Chief Executive Officer sold 6,126 shares at $13.01 ($79,717)
- 4 Open-market sale Chief Scientific Officer sold 5,000 shares at $17.53 ($87,656)
- 4 Open-market sale Chief Technical Officer sold 11,000 shares at $17.64 ($194,052)
- 4 Open-market sale Mahmood Nadir sold 7,500 shares at $18.03 ($135,215)
- 4 Open-market sale Chief Technical Officer sold 11,593 shares at $15.51 ($179,783)
- 4 Open-market sale Mahmood Nadir sold 7,500 shares at $15.32 ($114,900)
- 4 Open-market sale Chief Technical Officer sold 3,000 shares at $13.41 ($40,230)
- 4 Open-market sale Mahmood Nadir sold 7,500 shares at $13.40 ($100,480)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Executive Officer acquired 19,500 shares (grant or award)
- 4 Grant or award Mahmood Nadir acquired 6,000 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 8,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 5,000 shares (grant or award)
- 4 Grant or award Sr. VP, Technical Operations acquired 2,500 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 11 · 218 filings